Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy. [electronic resource]
Producer: 20000512Description: 729-36 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Agents -- therapeutic use
- Bone Marrow Cells -- pathology
- Bone Marrow Transplantation
- Combined Modality Therapy
- Cytarabine -- therapeutic use
- Disease-Free Survival
- Female
- Follow-Up Studies
- Fusion Proteins, bcr-abl -- genetics
- Genes, abl
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Karyotyping
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Recombinant Proteins
- Remission Induction
- Reverse Transcriptase Polymerase Chain Reaction
- Time Factors
- Transcription, Genetic
- Transplantation, Autologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.